| |
| |
| Exchange: |
N/A |
| Security
Type: |
N/A |
| Shares
Out: |
25,340,000 |
| Market
Cap: |
173.58(M) |
| Last
Volume: |
0 |
Avg
Vol: |
0 |
| 52
Week Range: |
$3.85 - $12.84 |
|
| Level
I Sector: |
N/A |
| Level
II Sector: |
N/A |
| Level
III Sector: |
N/A |
|
Member Indexes:
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 21.4 |
| Insider 3/6 Months : 22 |
|
| Guru Rank Number : - |
| Guru Rank Value : - |
| Guru Occurances : - |
|
|
|
|
|
| |
|
Company Profile Pulse Biosciences is a bioelectric medicine company. The CellFX® System (CellFX) is the commercial product to harness the distinctive advantages of Co.'s proprietary Nano-Pulse Stimulation™ (NPS) technology, such as the ability to non-thermally clear cells while sparing non-cellular tissue, to treat a variety of conditions for which an optimal solution remains unfulfilled. The CellFX System is a tunable, software-enabled, console-based platform, designed to accommodate the clinical workflow preferred by physicians. Co. has also designed an integrated cloud software infrastructure called CellFX CloudConnect™. CellFX CloudConnect also facilitates direct connectivity to the CellFX System.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
1,060,434 |
11,083,371 |
11,120,651 |
| Total Buy Value |
$0 |
$9,686,016 |
$74,935,336 |
$75,020,194 |
| Total People Bought |
0 |
3 |
3 |
3 |
| Total Buy Transactions |
0 |
16 |
17 |
20 |
| Total Shares Sold |
0 |
0 |
0 |
0 |
| Total Sell Value |
$0 |
$0 |
$0 |
$0 |
| Total People Sold |
0 |
0 |
0 |
0 |
| Total Sell Transactions |
0 |
0 |
0 |
0 |
| End Date |
2024-01-21 |
2023-10-20 |
2023-04-21 |
2022-04-21 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Duggan Robert W |
Director |
• • • |
2023-12-12 |
4 |
B |
$9.15 |
$164,691 |
D/D |
17,999 |
36,984,179 |
3.92 |
-23% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-11 |
4 |
B |
$9.36 |
$843,504 |
D/D |
90,118 |
36,966,180 |
3.92 |
-22% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-08 |
4 |
B |
$9.54 |
$1,112,898 |
D/D |
116,656 |
36,876,062 |
3.92 |
-24% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-07 |
4 |
B |
$9.19 |
$687,890 |
D/D |
74,852 |
36,759,406 |
3.92 |
-23% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-06 |
4 |
B |
$9.06 |
$750,286 |
D/D |
82,813 |
36,684,554 |
3.92 |
-18% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-06 |
4 |
OE |
$5.95 |
$59,101 |
D/D |
9,933 |
36,601,741 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-12-05 |
4 |
B |
$9.34 |
$616,636 |
I/I |
66,021 |
351,565 |
2.25 |
-17% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-04 |
4 |
B |
$10.38 |
$280,260 |
I/I |
27,000 |
285,544 |
2.25 |
-24% |
|
| Duggan Robert W |
Director |
• • • |
2023-12-04 |
4 |
OE |
$10.66 |
$430,099 |
D/D |
40,347 |
36,591,808 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-12-01 |
4 |
B |
$9.07 |
$413,592 |
I/I |
45,600 |
258,544 |
2.25 |
-21% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-30 |
4 |
B |
$9.06 |
$1,385,673 |
I/I |
152,944 |
212,944 |
2.25 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.21 |
$552,600 |
I/I |
60,000 |
60,000 |
2.25 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
B |
$9.44 |
$1,497,184 |
D/D |
158,600 |
36,551,461 |
3.92 |
-20% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-29 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,392,861 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-11-28 |
4 |
B |
$8.98 |
$1,117,085 |
D/D |
124,397 |
36,391,194 |
3.92 |
-14% |
|
| Duggan Robert W |
Director |
• • • |
2023-11-17 |
4 |
B |
$6.09 |
$123,470 |
D/D |
20,241 |
36,266,797 |
3.92 |
31% |
|
| Danahy Kevin Patrick |
Chief Executive Officer |
• • – |
2023-11-16 |
4 |
B |
$6.50 |
$35,156 |
D/D |
5,393 |
35,887 |
2.74 |
40% |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2023-11-15 |
4 |
B |
$5.80 |
$80,058 |
I/I |
13,539 |
1,039 |
1.99 |
32% |
|
| Levinson Mitchell E. |
Chief Strategy Officer |
• • – |
2023-11-15 |
4 |
B |
$5.83 |
$25,033 |
D/D |
4,261 |
73,027 |
2.74 |
32% |
|
| Zanganeh Maky |
Director |
• • – |
2023-11-13 |
4 |
OE |
$2.14 |
$162,801 |
D/D |
76,075 |
604,911 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-11-07 |
4 |
OE |
$5.95 |
$78,927 |
D/D |
13,265 |
36,246,556 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-08-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,233,291 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-07-25 |
4 |
OE |
$5.95 |
$9,919 |
D/D |
1,667 |
36,231,624 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-07-07 |
4 |
OE |
$2.14 |
$150,012 |
D/D |
67,133 |
36,229,957 |
|
- |
|
| Duggan Robert W |
Director |
• • • |
2023-07-05 |
4 |
OE |
$2.14 |
$139,100 |
D/D |
65,000 |
36,162,824 |
|
- |
|
128 Records found
|
|
Page 1 of 6 |
|
|
0.34 (4.73%) 
